Newsroom – Page 3

Home
-
Newsroom

~~Latest news~~

[Newsletter - 8] NEWS/INFOS

July 17,2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...

[Newsletter - 7] NEWS/INFOS

June 26, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

[Alerte actualité] Financement XENOTHERA

15 Juin 2020. Download the press release /Télécharger le communiqué

[Newsletter-6] NEWS/INFO

June 15, 2020. >> Breaking news / Edition spéciale << Download our...

[Newsletter-5] NEWS/INFOS

May 29, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

In the News/ A la une

Pays de la Loire (ma région) –Interview vidéo d’Odile Duvaux – Coronavirus...

[Newsletter -4] NEWS/INFOS

May 22, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

[Newsletter -3] NEWS/INFOS

May 15, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

[Newsletter -2] NEWS /INFOS

May 8, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

[Alerte actualité] Anticorps XAV19

30 avril 2020 Download the press release / Télécharger le communiqué

[Infographie] Traitement XAV19

Available here/Disponible ici

[Newsletter -1] NEWS / INFOS

May 1st, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

In the news / A la une

Journal des Entreprises – Coronavirus – XENOTHERA : « Nous prenons des risques entrepreneuriaux...

Covid-19 : Xenothera cherche les moyens de finaliser un traitement

[Article presse ] Par Frédéric Thual- La Tribune , à Nantes | 26/03/2020, 15:08 Avec...

COVID19 / XAV19 : Scientific and medical rationale

Français ci-dessous « We are convinced that our treatment will be efficient, for...

Interview d'Odile Duvaux, présidente de XENOTHERA dans Les Echos

[Article Presse] Par Emmanuel Guimard Publié le 20 mars 2020 à 17h14...

Le XAV19 de XENOTHERA, un traitement prometteur pour les cas graves de Coronavirus

[Communiqué ] Nantes , le 19 mars 2020 XENOTHERA pense détenir aujourd’hui...

XENOTHERA presents at Toulouse ONCOWEEK 2020

At ONCOWEEK 2020 that will take place in Toulouse on Feb. 3-5,...

The first patient has been injected 2 weeks ago

[ Communiqué ] Nantes, December 12th, 2019 XENOTHERA is pleased to give...

XENOTHERA receives approval for first in man Kidney Transplant Clinical Trial

Nantes, September 11th, 2019 – XENOTHERA announces it has received Czech Republic regulatory...

XENOTHERA presents at ESOT 2019

XENOTHERA will participate at ESOT 2019 that will take place...

XENOTHERA announces receivability of its Clinical Trial Application at the Czech Republic regulatory agency for a first in man clinical trial of LIS1 in kidney transplanted patients with dose escalation.

Nantes, June 21st, 2019 – XENOTHERA announces receivability after its submission of a Clinical...

Xenothera Announces Publication in European Journal of Clinical Investigation on Immunological Mechanisms Underlining Use of LIS1

Kidney graft recipients receiving anti-lymphocyte globulins of animal origin undergo unwanted immune...

XENOTHERA to raise Series A

XENOTHERA has started to gather investors for a Series A round of...